Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 2/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.30 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL30071055 | 0.89 | TDP1 (0.44) | CA1CA2TDP1FDPS | |
| SCHEMBL23301461 | 0.89 | ALDH1A1 (0.38) | CA1CA2FDPSHDAC8 | |
| Sulfuric Acid SCHEMBL30240036 | 0.87 | TDP1 (0.38) | CA1CA2TDP1FDPSHDAC8 | |
| Acetic Acid SCHEMBL23301829 | 0.87 | THRB (0.33) | CA1CA2 | |
| Hydrochloric Acid SCHEMBL23301430 | 0.87 | CA1 (0.39) | CA1CA2HDAC8 | |
| Bromide SCHEMBL30070960 | 0.87 | ALDH1A1 (0.37) | CA1CA2HDAC8 | |
| Iodide SCHEMBL30071069 | 0.87 | ALDH1A1 (0.37) | CA1CA2HDAC8 | |
| SCHEMBL30578239 | 0.84 | TDP1 (0.38) | CA1CA2TDP1 | |
| Benzylimidazole SCHEMBL16236716 | 0.81 | ALDH1A1 (0.41) | — | |
| Acetic Acid SCHEMBL30071122 | 0.80 | CA1 (0.41) | CA1CA2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3166981-B1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12514267-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2026-01-06 | — | — | US | disclosed |
| US-12410206-B2 | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250057202-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2025-02-20 | — | — | US | disclosed |
| EP-3459975-B1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2024-10-02 | — | — | EP | disclosed |
| CN-113056488-B | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | DSM营养产品有限责任公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. | 2023-08-17 | — | — | US | disclosed |
| US-11697692-B2 | Methods of producing glycan polymers | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-07-11 | — | — | US | disclosed |
| EP-4205553-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | DSM Nutritional Products, LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | DSM NUTRITIONAL PRODUCTS, LLC | 2022-12-29 | — | — | US | disclosed |
| US-20220400728-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-12-22 | — | — | US | disclosed |
| EP-3636077-B1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-11-16 | — | — | EP | disclosed |
| WO-2021083997-A1 | NOVEL MICELLAR CATALYSTS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2021-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | FUT5, FUT6, OSTC | CA1 1066/4885CA2 3904/4885TDP1 4759/4885 |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | OSTC, FUT5, FUT6 | CA1 282/4885CA2 1138/4885TDP1 4531/4885 |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | FUT5, FUT6, OSTC | CA1 1066/4885CA2 3904/4885TDP1 4759/4885 |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | FUT6, FUT5, PIGS | CA1 2772/4885CA2 4215/4885TDP1 4614/4885 |
| US-12410206-B2 | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | OAT, OTC, FUCA2 | CA1 1946/4885CA2 2648/4885TDP1 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.